The transaction's two focuses, Palsonify and atumelnant, have combined peak sales potential of more than $5 billion, Vertex ...
Vertex claimed the two drugs in the deal could eventually bring in more than $5 billion annually. Still, the high price it ...
Immune checkpoint inhibitors (ICPis) have proven extremely efficacious in cancer therapy but also lead to a plethora of immune-related adverse events (irAEs). The endocrine irAEs are not only quite ...
A new review was published in Volume 18 of Aging on June 11, 2026, titled "Age-related dysfunctions of the neuroendocrine ...
Credit: Getty Images We spoke with endocrinologists to explore the potential of artificial intelligence in the management of chronic disease, including diabetes, obesity, and PCOS. Artificial ...
Women who have close family members with endocrine diseases--including type 2 diabetes, thyroid diseases and polycystic ovary syndrome (PCOS)--are at higher risk of pregnancy loss, a new study has ...
Morning Overview on MSN
A popular joint-pain supplement sold over the counter is now tied to hidden hormone disruption
Federal regulators have confirmed that Artri King, a widely sold over-the-counter joint-pain supplement, contains undisclosed ...
(Beyond Pesticides, October 8, 2024) A comprehensive literature review in Endocrines, published in September, amasses hundreds of studies on endocrine-disrupting chemicals (EDCs) that showcase adverse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results